Medical device maker Zynex Inc. appointed Joshua Disbrow as an independent board member.
Disbrow currently serves as the chairman and CEO of Colorado-based Aytu BioScience Inc.
Zynex appoints Aytu BioScience CEO to board
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Medical device maker Zynex Inc. appointed Joshua Disbrow as an independent board member.
Disbrow currently serves as the chairman and CEO of Colorado-based Aytu BioScience Inc.